Multiple bilateral retinal breaks as a long-term complication of retinopathy of prematurity treated with intravitreal bevacizumab

Discussion: Patients with a history of ROP have a lifelong increased risk of retinal tears, and the long-term effects of intravitreal anti–vascular endothelial growth factor therapy for ROP are not well understood or documented. It is unknown whether there are differences in the rates of long-term ocular complications of ROP after anti–vascular endothelial growth factor versus laser treatment of ROP. Studies are needed to compare the long-term benefits and risks associated with both approaches.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research